Palo Alto Investors’s Generation Bio GBIO Stock Holding History

Palo Alto Investors’s Portfolio GBIO Stock Details GBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,047	Closed	-$85.5K	–	53
2025 Q4	$85.5K	Hold	15,047	–	–	0.01%	48
2025 Q3	$92.1K	Sell	15,047 -1	-0%	-$5	0.02%	44
2025 Q2	$48.2K	Hold	15,048	–	–	0.01%	45
2025 Q1	$60.9K	Hold	15,048	–	–	0.01%	44
2024 Q4	$160K	Hold	15,048	–	–	0.02%	43
2024 Q3	$372K	Hold	15,048	–	–	0.05%	42
2024 Q2	$424K	Buy	+15,048	New	+$489K	0.05%	38

Other funds holding GBIO

ACM

Accent Capital Management Centerville, Ohio $231M AUM 33.86% 1-Year Est. Return

Palo Alto Investors's GBIO Position: Q1 2026 in Review

Palo Alto Investors sold out of Generation Bio (GBIO) in Q1 2026, closing a stake of 15,047 shares — an estimated $85.5K sold.

Palo Alto Investors first reported a position in GBIO in Q2 2024 and held it in 7 quarters. The position peaked at $424K in Q2 2024. 2 funds tracked by Wall St. Rank hold GBIO as of Q1 2026.

Palo Alto Investors reported no remaining Generation Bio position as of Q1 2026 after selling out during the quarter.
Palo Alto Investors sold 15,047 Generation Bio shares in Q1 2026, an estimated $85.5K.
Palo Alto Investors first reported a position in Generation Bio in Q2 2024 and held it in 7 quarters.
Palo Alto Investors's Generation Bio position peaked at $424K in Q2 2024.
2 funds tracked by Wall St. Rank held Generation Bio as of Q1 2026.

Based on Palo Alto Investors's 13F filing for Q1 2026, filed 15 May 2026.